sunvozertinib
dizal pharmaceuticals
['sunvozertinib', 'nsclc', 'sclc', 'dizal']
we are presenting data of sunvozertinib showing the best-in-class potential in advanced nsclc with exon20ins mutations and encouraging anti-tumor efficacy in pretreated advanced nsclc after failure of egfr tki treatment.
#asco23 #exon20ins #nsclc #oncology 
Dizal is a clinical stage, biopharmaceutical company dedicated to differentiated therapeutics for the treatment of cancer and immunological diseases.